Subscribe to RSS
DOI: 10.1055/s-0044-102297
Narrow band imaging efficiency in evaluation of mucosal healing/relapse of ulcerative colitis
Publication History
submitted 18 September 2017
accepted after revision 10 January 2018
Publication Date:
18 April 2018 (online)
Abstract
Background and study aims Mucosal healing is a current treatment target in ulcerative colitis (UC), while histological remission is another target. The aim of this study was to evaluate the efficiency of magnified narrow band imaging (NBI) findings of mucosal healing and their relationship with histological activity and prognosis.
Patients and methods Patients with UC who underwent total colonoscopy between January 2010 and December 2012 with left-sided or total-colitis type UC and achieved clinical remission with an endoscopic Mayo score of 0 or 1 were included. Each colon section was observed with white light and magnified NBI, with the colonoscopy being repeated at 1-year follow-up. We assessed the relationships of magnified NBI with histological disease activity and prognosis. Magnified NBI findings were divided into three categories; honeycomb-like blood vessels (BV-H), blood vessels shaped like bare branches (BV-BB), and blood vessels shaped like vines (BV-V).
Results Fifty-two patients were included. The percentage of remitted mucosa with BV-BB was 37 %, while that of mucosa with scars with BV-H was 35 %. BV-H and BV-BB did not show pathological activity (12/292 and 8/299, respectively), while BV-V showed high pathological activity (27/33, 81 %). There was a correlation between magnified NBI findings and pathological findings (P < 0.01). The odds ratio for inflammation activity at 1-year follow-up was 14.2 for BV-BB (95 % CI, 3.3 – 60.9)
Conclusion Magnified NBI findings showed a good relationship with histological activity. This suggests that we could estimate histological activity without biopsy, and also the possibility of predicting relapse over the following year.
-
References
- 1 Travis SP, Haggins PD, Orchard T. et al. Review article: defining remission in ulcerative colitis. Aliment Pharmacol Ther 2011; 34: 113-124
- 2 Peyrin-Biroulet L, Sandborn W, Sands BE. et al. Selecting therapeutic targets in inflammatory bowel disease (STRIDE). Am J Gastroenterol 2015; 110: 1324-38
- 3 Peyrin-Biroulet L, Ferrante M, Magro F. et al. Results from the 2nd Scientific Workshop of the ECCO (I): Impact of mucosal healing on the course of inflammatory bowel disease. J Crohns Colitis 2011; 5: 477-483
- 4 Rutgeerts P, Vermeire S, Van Assche G. et al. Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target?. Gut 2007; 56: 453-455
- 5 Sandborn WJ, Hanauer S, Van Assche G. et al. Treating beyond symptoms with a review to improving patient outcomes in inflammatory bowel diseases. J Crohns Colitis 2014; 8: 927-935
- 6 Colombel JF, Rutgeerts P, Reinsch W. et al. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Gastroenterology 2011; 141: 1194-1201
- 7 Danese S, Fiorino G, Angelucci E. et al. Narrow-band imaging endoscopy to assess mucosal angiogenesis in inflammatory bowel disease: A pilot study. World J Gastroenterol 2010; 16: 2396-2400
- 8 Pousa ID, Gisbert JM, Gisbert JP. et al. Angiogenesis in inflammatory bowel disease. Eur J Clin Invest 2008; 38: 73-81
- 9 Adachi S, Arakawa H, Koyama S. et al. Correlation between endoscopic healing and histological healing of ulcerative colitis determined using the Mayo score. Progress Digest Endosc 2014; 85: 43-46
- 10 Samaan MA, Mosli MH, Sandborn WL. et al. A systematic review of the measurement of endoscopic healing in ulcerative colitis clinical trials: Recommendations and implications for future research. Inflamm Bowel Dis 2014; 20: 1465-1771
- 11 Bryant RV, Burger DC, Delo J. et al. Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalization over 6 years of follow-up. Gut 2016; 65: 408-414
- 12 D’Haens G, Sandborn WJ, Feagan BG. et al. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology 2007; 132: 763-786
- 13 Kudo T, Matsumoto T, Esaki M. et al. Mucosal vascular pattern in ulcerative colitis: observations using narrow band imaging colonoscopy with special reference to histologic inflammation. Int J Colorectal Dis 2009; 24: 495-501
- 14 Esaki M, Kubokura N, Kudo T. et al. Endoscopic findings under narrow band imaging colonoscopy in ulcerative colitis. Digest Endosc 2011; 23: 140-142
- 15 Matsumoto T, Kudo T, Jo Y. et al. Magnifying colonoscopy with narrow band imaging system for the diagnosis of dysplasia in ulcerative colitis: A pilot study. Gastrointest Endosc 2007; 66: 957-965
- 16 Iacucci M, Ghosh S. Looking beyond symptom relief: evaluation of mucosal healing in inflammatory bowel disease. Therap Adv Gastroenterol 2011; 4: 129-143
- 17 Travis SP, Schnell D, Krzeski P. et al. Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS). Gut 2012; 61: 535-642
- 18 Cromer WE, Mathis JM, Granger DN. et al. Role of the endothelium in inflammatory bowel diseases. World J Gastroenterol 2011; 17: 578-593
- 19 Danese S, Sans M, Motte C. et al. Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. Gastroenterology 2006; 130: 2060-2073
- 20 Bessho R, Kanai T, Hosoe N. et al. Correlation between endocytoscopy and conventional histopathology in microstructural features of ulcerative colitis. J Gastroenterol 2011; 46: 1197-1202
- 21 Maeda Y, Ohtsuka K, Kudo SE. et al. Endocytoscopic narrow-band imaging efficiency for evaluation of inflammatory activity in ulcerative colitis. World J Gastroenterol 2015; 21: 2108-2115
- 22 Nishio Y, Ando T, Maeda O. et al. Pit patterns in rectal mucosa assessed by magnifying colonoscope are predictive of relapse in patients with quiescent ulcerative colitis. Gut 2006; 55: 1768-1773
- 23 Iacucci M, Gasia MF, Hassan C. et al. Complete mucosal healing defined by endoscopic Mayo subscore still demonstrates abnormalities by novel high definition colonoscopy and refined histological gradings. Endoscopy 2015; 47: 726-734
- 24 Neumann H, Vieth M, Gunther C. et al. Virtual chromoendoscopy for prediction of severity and disease extent in patients with inflammatory bowel disease: a randomized controlled study. Inflamm Bowel Dis 2013; 19: 1935-1942